<i>EGFR</i> and <i>MET</i> Amplifications Determine Response to HER2 Inhibition in <i>ERBB2</i> -Amplified Esophagogastric Cancer
Francisco Sánchez-Vega(Memorial Sloan Kettering Cancer Center), Yelena Y. Janjigian(Memorial Sloan Kettering Cancer Center), Elisa de Stanchina(Memorial Sloan Kettering Cancer Center), Karen T. Brown(NewYork–Presbyterian Hospital), Neeta Pandit‐Taskar(Memorial Sloan Kettering Cancer Center), Richard B. Lanman(C.T. de Wit Graduate School for Production Ecology and Resource Conservation), Steven M. Larson(Memorial Sloan Kettering Cancer Center), Heiko Schöder(Memorial Sloan Kettering Cancer Center), Nancy Bouvier(University of California, San Francisco), Jaclyn F. Hechtman(Caris Life Sciences (United States)), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), David H. Ilson(Memorial Sloan Kettering Cancer Center), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Christopher J. Fong(Memorial Sloan Kettering Cancer Center), Mark Schattner(Memorial Sloan Kettering Cancer Center), Joanne Soong(Cornell University), Helen Won(Unknown), Christine A. Iacobuzio–Donahue(Johns Hopkins University), Todd Hembrough(OncoPlex Diagnostics (United States)), Marinela Capanu(Memorial Sloan Kettering Cancer Center), Gouri J. Nanjangud(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center), Marissa S. Mattar(Memorial Sloan Kettering Cancer Center), Robert A. Lefkowitz(Memorial Sloan Kettering Cancer Center), Jorge A. Carrasquillo(National Institutes of Health), Yaelle Tuvy(Memorial Sloan Kettering Cancer Center), Geoffrey Y. Ku(Memorial Sloan Kettering Cancer Center), Jason S. Lewis(Memorial Sloan Kettering Cancer Center), Besnik Qeriqi(Memorial Sloan Kettering Cancer Center), David P. Kelsen(Memorial Sloan Kettering Cancer Center), Wolfgang Weber(Nuklearmedizinische Klinik des Klinikums rechts der Isar), Pau Castel(Memorial Sloan Kettering Cancer Center), Efsevia Vakiani(Memorial Sloan Kettering Cancer Center), Rebecca J. Nagy(Guardant (United States)), Yuan Tian(University of Maryland Rehabilitation & Orthopaedic Institute), Mario E. Lacouture(Garden City Community College), David B. Solit(Memorial Sloan Kettering Cancer Center), Maurizio Scaltriti(Harvard University)
Cited by 147
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k